findmyKOL
Clinical trialNCT03222492CompletedPhase 1/PHASE2Interventional

Brentuximab Vedotin for Systemic Sclerosis

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment17Diffuse Cutaneous Systemic SclerosisSclerodermadcSSc
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Medical Center: Division of Rheumatology

    Los Angeles, California, United States

  • Georgetown University Medical Center: Division of Rheumatology

    Washington D.C., District of Columbia, United States

  • University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology

    Ann Arbor, Michigan, United States

  • Hospital for Special Surgery, New York: Division of Rheumatology

    New York, New York, United States

  • Duke University Medical Center: Division of Rheumatology and Immunology

    Durham, North Carolina, United States

  • University of Pittsburgh Medical Center: Division of Rheumatology and Clinical

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina: Division of Rheumatology & Immunology

    Charleston, South Carolina, United States

  • University of Texas Houston Medical School: Division of Rheumatology and Clinical Immunogenetics

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Sept 2017
Primary completion
10 Apr 2023
Completion
10 Apr 2023
Last update posted
5 May 2026
Registered enrollment
17
Registry id
NCT03222492

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.